Market News (Page 18) - TendieTensor

Market News Page 18 of 159 • 3,956 articles

SOC as a Service (SOCaaS) Market to Reach USD 15.61 Billion by 2032, Driven by Rising Cyber Threats and Demand for 24/7 Expert Monitoring | SNS Insider

GlobeNewswire Inc. • Sns Insider

SOC as a Service (SOCaaS) Market to Reach USD 15.61 Billion by 2032, Driven by Rising Cyber Threats and Demand for 24/7 Expert Monitoring | SNS Insider

11/25/2025 10:00 AM • The SOC as a Service market is projected to grow from USD 6.86 billion in 2024 to USD 15.61 billion by 2032, driven by increasing cyber threats, cloud adoption, and compliance demands. North America leads the market, with the U.S. expected to reach USD 3.15 billion by 2032.

THLLY - Introduced GenAI4SOC, a generative AI solution for Security Operations Centers, demonstrating innovation in cybersecurity technology

#cybersecurity #SOCaaS #threat detection #cloud security #managed services

LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit with the Schall Law Firm

11/25/2025 10:00 AM • The Schall Law Firm is pursuing a class action lawsuit against Stride, Inc. for alleged securities fraud, claiming the company made false statements about enrollment numbers, staffing practices, and compliance requirements during the period of October 22, 2024 to October 28, 2025.

LRN - The lawsuit alleges multiple serious misconduct issues including inflating enrollment numbers with 'ghost students', exceeding statutory staffing limits, failing background checks, and suppressing whistleblower reports to improve profit margins

#securities fraud #class action lawsuit #enrollment manipulation #compliance violation

Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX

GlobeNewswire Inc. • Djs Law Group

Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX

11/25/2025 10:00 AM • Baxter International is facing a class action lawsuit alleging false statements about its Novum IQ Large Volume Pump, which potentially put patients at risk of serious injury or death due to medication infusion defects.

RWAYZ - Positive dividend announcement, clear financial communication, and strategic focus on providing alternative capital solutions indicate a stable and confident company position
BAX - Lawsuit alleges company made false statements and failed to address serious product defects that could harm patients, indicating significant corporate misconduct and potential legal liability

#securities lawsuit #medical device #patient safety #class action

Physical AI Market Size to Expand at 31.26% CAGR, to Capture USD 61.19 Billion 2034

GlobeNewswire Inc. • Towards Healthcare

Physical AI Market Size to Expand at 31.26% CAGR, to Capture USD 61.19 Billion 2034

11/25/2025 10:00 AM • The global physical AI market is projected to grow from $4.12 billion in 2024 to $61.19 billion by 2034, with a 31.26% CAGR, driven by advances in robotics, AI-enabled surgery, and automation across healthcare, manufacturing, and logistics sectors.

RWAYL - Positive dividend announcement, clear financial communication, and strategic focus on providing alternative capital solutions indicate a stable and confident company position
TEM - Listed as a key player in emerging physical AI market with strong growth potential

#physical AI #robotics #surgical robots #healthcare automation #AI technologies

FALCON GOLD ESTABLISHES NEW GOLD CAMP IN CENTRAL NEWFOUNDLAND AND ENGAGES GEOXPLORE SURVEYS INC - FOR AGGRESSIVE PHASE 1 EXPLORATION

Benzinga • Prnewswire

FALCON GOLD ESTABLISHES NEW GOLD CAMP IN CENTRAL NEWFOUNDLAND AND ENGAGES GEOXPLORE SURVEYS INC - FOR AGGRESSIVE PHASE 1 EXPLORATION

11/25/2025 09:37 AM • Falcon Gold Corp has acquired a 17,225-hectare land package in central Newfoundland along the Valentine Lake Fault System and engaged GeoXplore Surveys Inc. to conduct an aggressive Phase 1 exploration program targeting gold discovery potential.

AMZN - Securing significant AI infrastructure deal with OpenAI, demonstrating strategic commitment to AI technology
EQX - Mentioned as operating the Valentine Gold Mine in the same geological region

#gold exploration #Newfoundland #mineral exploration #Valentine Lake Fault System

Q3 2025 Contract Research Organization (CRO) Activity and Intel Report Featuring ICON, Astrazeneca, Akesobio, CSPPC Pharmaceutical, ImmunityBio, and Boryung

GlobeNewswire Inc. • Researchandmarkets.Com

Q3 2025 Contract Research Organization (CRO) Activity and Intel Report Featuring ICON, Astrazeneca, Akesobio, CSPPC Pharmaceutical, ImmunityBio, and Boryung

11/25/2025 09:00 AM • A comprehensive report analyzing Q3 2025 CRO industry trends, focusing on clinical trial activities across different regions, therapeutic areas, and development phases.

AZN - Mentioned as a featured company in the CRO report without specific performance details

#CRO #clinical trials #pharmaceutical research #market trends #therapeutic areas

Portnoy Law Firm Announces Class Action on Behalf of Molina Healthcare, Inc. Investors

GlobeNewswire Inc. • Lesley F. Portnoy

Portnoy Law Firm Announces Class Action on Behalf of Molina Healthcare, Inc. Investors

11/25/2025 09:00 AM • Portnoy Law Firm announces a class action lawsuit for Molina Healthcare investors who purchased securities between February and July 2025, following significant earnings guidance reductions due to medical cost pressures.

MOH - Company reduced full-year earnings guidance twice within two weeks, citing challenging medical cost trends, resulting in a 16.84% stock price drop and potential investor losses

#class action #lawsuit #earnings guidance #medical costs #stock decline

Portnoy Law Firm Announces Class Action on Behalf of Cepton, Inc. Investors

GlobeNewswire Inc. • Lesley F. Portnoy

Portnoy Law Firm Announces Class Action on Behalf of Cepton, Inc. Investors

11/25/2025 09:00 AM • The Portnoy Law Firm is initiating a class action lawsuit against Cepton, alleging the company made false and misleading statements during its acquisition process with Koito, potentially depriving shareholders of a more valuable alternative offer.

KOTMY - Mentioned as the acquiring company in the transaction, but no specific negative or positive claims are made directly about Koito

#class action #lawsuit #securities #acquisition #shareholder rights

Global AI in Medical Imaging Market Set to Surge to USD 4.54 Billion by 2029 | MarketsandMarkets™

GlobeNewswire Inc. • Marketsandmarkets

Global AI in Medical Imaging Market Set to Surge to USD 4.54 Billion by 2029 | MarketsandMarkets™

11/25/2025 09:00 AM • The global AI in medical imaging market is projected to expand from $1.5 billion in 2024 to $4.5 billion by 2029, driven by workforce shortages, rising imaging demand, and strategic cross-industry partnerships in healthcare technology.

MSFT - Actively partnering with medical institutions and expanding AI collaboration, demonstrating strategic leadership in medical imaging technology

#AI #medical imaging #healthcare #diagnostics #technology

Portnoy Law Firm Announces Class Action on Behalf of Marex Group plc. Investors

GlobeNewswire Inc. • Lesley F. Portnoy

Portnoy Law Firm Announces Class Action on Behalf of Marex Group plc. Investors

11/25/2025 09:00 AM • The Portnoy Law Firm announced a class action lawsuit against Marex Group plc, alleging accounting misconduct after NINGI Research published a critical report suggesting financial irregularities, causing the stock to drop 6.19%.

JNJ - Original manufacturer of Simponi®, mentioned as trademark owner with no direct action in this announcement
MRX - NINGI Research accused the company of engaging in a multi-year accounting scheme involving fictitious transactions, misleading disclosures, and concealing significant losses, which led to a stock price decline and potential legal action

#class action #accounting scheme #financial misconduct #stock drop

INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025

GlobeNewswire Inc. • Steve Shum, Ceo

INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025

11/25/2025 09:00 AM • INVO Fertility will implement a 1-for-8 reverse stock split effective November 28, 2025, reducing outstanding shares to approximately 1,891,151 and adjusting authorized shares to 6,250,000.

ALVOW - Successfully received marketing authorisations, expanding product portfolio and demonstrating development capabilities in biosimilar medicines
IVF - The reverse stock split suggests the company is managing its stock structure, which is typically a strategic financial maneuver to maintain NASDAQ listing requirements or adjust share price, without clear positive or negative implications

#reverse stock split #fertility #stock market #NASDAQ

Compliant Launches Agentic AI Suite for Programmatic Media

GlobeNewswire Inc. • Jamie Barnard

Compliant Launches Agentic AI Suite for Programmatic Media

11/25/2025 09:00 AM • Compliant introduces a new AI suite addressing data privacy concerns in programmatic advertising, enabling responsible AI-powered media buying with a Data Integrity Index covering 95% of global media impressions.

GOOG - Mentioned in context of emerging Agent-to-Agent protocols, with no specific positive or negative implications

#AI #programmatic advertising #data privacy #media buying #digital media

Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors

GlobeNewswire Inc. • Lesley F. Portnoy

Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors

11/25/2025 09:00 AM • The Portnoy Law Firm is advising aTyr Pharma investors about a potential class action lawsuit related to securities purchased between January 16 and September 12, 2025, following a failed Phase 3 clinical trial for efzofitimod.

ATYR - Stock price fell sharply after announcing that their Phase 3 clinical trial for efzofitimod failed to meet its primary endpoint, indicating significant negative business impact

#class action #lawsuit #securities #clinical trial #pharmaceutical

Fund Takes Bold New Position: Is Transocean Stock a Good Buy?

The Motley Fool • Jake Lerch

Fund Takes Bold New Position: Is Transocean Stock a Good Buy?

11/25/2025 08:32 AM • Ninepoint Partners LP acquired 6 million shares of Transocean, valued at $18.7 million, representing a new position in the offshore drilling company despite its recent underperformance in the stock market.

RIG - While Ninepoint made a significant investment, the company has been unprofitable since 2016, with stock performance lagging the S&P 500. However, recent improvements in balance sheet and quarterly earnings provide some positive indicators.

#offshore drilling #institutional investment #stock performance #energy sector

Septerna to Participate in 8th Annual Evercore Healthcare Conference

GlobeNewswire Inc. • Renee Leck/Carly Scaduto

Septerna to Participate in 8th Annual Evercore Healthcare Conference

11/25/2025 08:00 AM • Septerna, a clinical-stage biotechnology company specializing in GPCR drug discovery, will participate in the 8th Annual Evercore Healthcare Conference on December 2, 2025, presenting via live webcast.

JNJ - Upprunalega framleiðandi Simponi lyfsins, sem nú fær samkeppni frá hliðstæðu
SEPN - Company is showcasing ongoing clinical trials, highlighting progress in drug development (SEP-479 and SEP-631), and maintaining a robust financial position of $561.6 million

#biotechnology #GPCR #drug discovery #healthcare conference #webcast

Boca Raton Community Middle School Enhances Career Exploration With zSpace AR/VR Technology

GlobeNewswire Inc. • Zspace, Inc.

Boca Raton Community Middle School Enhances Career Exploration With zSpace AR/VR Technology

11/25/2025 08:00 AM • Boca Raton Community Middle School implemented a zSpace AR/VR learning lab to enhance student engagement and career exploration, allowing students to simulate real-world skills and discover potential career paths through immersive technology.

ALVOW - Fyrirtækið fékk markaðsleyfi fyrir nýtt lyf og styrkti stöðu sína sem líftæknifyrirtæki
ZSPC - The company's technology is shown to positively impact student learning, engagement, and career awareness, with students expressing excitement about exploring different career paths through the AR/VR platform

#augmented reality #career exploration #education technology #immersive learning

Ollie’s Bargain Outlet Holdings, Inc. Announces Third Quarter Fiscal 2025 Earnings Release Date and Conference Call Information

GlobeNewswire Inc. • Ollie'S Bargain Outlet Holdings, Inc.

Ollie’s Bargain Outlet Holdings, Inc. Announces Third Quarter Fiscal 2025 Earnings Release Date and Conference Call Information

11/25/2025 08:00 AM • Ollie's Bargain Outlet will report its Q3 fiscal 2025 financial results on December 9, 2025, with a conference call at 8:30 a.m. Eastern Time to discuss performance and answer investor questions.

OLLI - The company is reporting earnings, has grown to 613 stores across 34 states, and appears confident in its business model of selling brand name products at discounted prices

#earnings #financial results #conference call #retail #off-price retailer

UroGen Pharma to Present at the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire Inc. • Urogen Pharma Ltd.

UroGen Pharma to Present at the Piper Sandler 37th Annual Healthcare Conference

11/25/2025 08:00 AM • UroGen Pharma will present at the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025, in a fireside chat format, discussing their innovative cancer treatment technologies.

CYCUW - Briefly mentioned in a partnership context with no specific performance details
URGN - Company is presenting at a major healthcare conference, showcasing positive clinical trial results with a 77.8% complete response rate in Phase 3 UTOPIA trial, and receiving FDA agreement on NDA submission strategy

#biotech #cancer treatment #urothelial cancer #healthcare conference

Compass Therapeutics to Participate in Upcoming December Investor Events

GlobeNewswire Inc. • Compass Therapeutics

Compass Therapeutics to Participate in Upcoming December Investor Events

11/25/2025 08:00 AM • Compass Therapeutics announced participation in two healthcare investor conferences in December 2025, highlighting their ongoing clinical-stage oncology research focused on antibody-based therapeutics targeting tumor growth and immune system interactions.

CYCU - Briefly mentioned in a partnership context with no specific performance details
CMPX - Company is presenting at multiple investor conferences, showing ongoing research progress in developing novel cancer treatment antibodies with promising preclinical data on CTX-10726 demonstrating tumor elimination in studies

#oncology #biopharmaceutical #antibody therapeutics #cancer research #investor conferences

Black Rock Coffee Bar Announces Participation in the Morgan Stanley Global Consumer & Retail Conference

GlobeNewswire Inc. • Black Rock Coffee Bar, Inc.

Black Rock Coffee Bar Announces Participation in the Morgan Stanley Global Consumer & Retail Conference

11/25/2025 08:00 AM • Black Rock Coffee Bar will participate in the Morgan Stanley Global Consumer & Retail Conference on December 2, 2025, in New York, featuring management meetings and a fireside chat at 3:00 p.m. EST.

BRCB - Company is highlighting growth, expansion to 170+ locations across seven states, and actively engaging with investors through conference participation

#conference #investor relations #coffee retailer #Morgan Stanley

GraniteShares Expands YieldBOOST™ Lineup with Two New ETFs on Quantum Computing Leaders RGYY and QBYY

GlobeNewswire Inc. • Will Rhind

GraniteShares Expands YieldBOOST™ Lineup with Two New ETFs on Quantum Computing Leaders RGYY and QBYY

11/25/2025 08:00 AM • GraniteShares launched two new ETFs (RGYY and QBYY) focused on quantum computing companies Rigetti Computing and D-Wave Quantum, designed to generate income through options strategies on leveraged ETFs.

RGTI - Described as a pioneer in superconducting quantum integrated circuits and a leading quantum hardware developer

#quantum computing #ETF #options strategy #income generation

Aclaris Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire Inc. • Will Roberts

Aclaris Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

11/25/2025 08:00 AM • Aclaris Therapeutics will participate in the Piper Sandler 37th Annual Healthcare Conference in New York City on December 2, 2025, with CEO Dr. Neal Walker presenting a fireside chat.

CMG - Historical example of successful recovery after significant market downturn, demonstrating long-term growth potential with 3,480% returns since IPO
ACRS - The article is a routine conference participation announcement with no significant positive or negative financial indicators, representing a standard corporate communication

#healthcare conference #biopharmaceutical #investor relations #webcast

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc. • Carlo Tanzi, Ph.D.

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

11/25/2025 07:00 AM • Climb Bio granted a non-statutory stock option to a new employee for 120,000 shares at $1.76 per share, vesting over four years with standard stock option terms.

NVDA - Mentioned as a technology partner for Lucid's autonomous vehicle development, with no strong positive or negative implications
CLYM - Standard employee stock option grant with typical vesting schedule, indicating routine business activity without significant positive or negative implications

#equity award #stock option #biotechnology #inducement plan

OTC Markets Group Welcomes Compass Group PLC to OTCQX

GlobeNewswire Inc. • Otc Markets Group Inc.

OTC Markets Group Welcomes Compass Group PLC to OTCQX

11/25/2025 07:00 AM • Compass Group PLC, a global food services company, has upgraded to trade on the OTCQX Best Market, aiming to improve accessibility for U.S. investors and provide transparent trading.

CMPGY - The company is expanding its market presence, demonstrating growth by qualifying for OTCQX and emphasizing the importance of the U.S. market in its strategy

#food services #international trading #OTCQX #market upgrade

Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader

GlobeNewswire Inc. • Kymera Therapeutics

Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader

11/25/2025 07:00 AM • Kymera Therapeutics initiated dosing in its BROADEN2 Phase 2b clinical trial for KT-621, an oral STAT6 degrader targeting moderate to severe atopic dermatitis. The company expects to report trial data by mid-2027 and is also preparing for a Phase 2b asthma trial in early 2026.

GRABW - Strong growth in multiple segments (23% delivery growth, 39% fintech growth), expanding middle-class market, raised full-year guidance, positive analyst ratings (7 Buy, 5 Hold), and institutional ownership of 55% support a bullish outlook
KYMR - The company is advancing a novel drug candidate (KT-621) across multiple clinical trials, demonstrating progress in developing a potential first-in-class treatment for immunological diseases

#STAT6 #atopic dermatitis #clinical trial #drug development #immunological diseases